Skip to content

Evaluation test for improvement of eye fatigue by single intake of test food.

Evaluation test for improvement of eye fatigue by single intake of test food. - Evaluation test for improvement of eye fatigue by single intake of test food.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000055841
Enrollment
28
Registered
2025-10-16
Start date
2024-11-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

[1] Oral ingestion of a test food (1 tablet). [2] Observation. [3] Oral ingestion of a placebo food (1 tablet). [4] Observation. [1] Oral ingestion of a placebo food (1 tablet). [2] Observation.

Sponsors

TES Holdings Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Japanese males and females aged 20-64 years. 2) Individuals who are healthy and are not received treatment of disease. 3) Individuals who feel eye fatigue and thirst 4) Individuals who have binocular vision of 0.7 or better with naked eye or corrected vision, and who do not wear contact lenses. 5) Individuals whose written informed consent has been obtained. 6) Individuals who can come to the designated venue for this study and be inspected. 7) Individuals judged appropriate for the study by the principal.

Exclusion criteria

Exclusion criteria: 1)Individuals using medical products. 2)Individuals with a confirmed diagnosis of dry eye or suspected dry eye. 3)Individuals who are using eye drops for the treatment of ocular diseases. 4)Individuals who have been diagnosed with presbyopia or are aware of presbyopia. 5)Individuals with eye diseases, entropion, or trichiasis. 6)Individuals who have a history of LASIK vision restoration surgery or intraocular lens surgery. 7)Individuals who use artificial tears more than 6 times a day in everyday life. 8)Individuals who regularly use contact lenses to correct their vision. 9)Individuals with a history or current history of mental illness, sleep disorders, hypertension, diabetes, dyslipidemia, eye disease or serious illness. 10)Individuals with a serious or current medical history of liver, kidney, heart, lung, blood, etc. 11)Individuals who are a patient or have a history of or endocrine disease. 12)Individuals who used a drug to treat a disease in the past 1 month. 13)Individuals with drug and food allergies. 14)Individuals who are a smoker. 15)Individuals who are currently, or within the past 3 months have been, in the habit of continuously consuming functional foods, health foods, or supplements containing lactobacilli or claiming visual function, and those who plan to consume such foods during the study period. 16)Individuals who excessively take alcohol (60 g/day in pure alcohol equivalent). 17)Individuals who may change their lifestyle during the examination period. 18)Individuals who have difficulty in inputting text in English using a personal computer and persons who can easily input text using a personal computer. 19)Individuals who engage in a night work. 20)Individuals who are or are possibly pregnant, or are lactating. 21)Individuals who participated in other clinical studies in the past 3 months. 22)Individuals who are or whose family is engaged in healthy or functional foods. 23)Individuals judged inappropriate for the study by the principal.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale (Observation period I and II : before and after loading)

Countries

Japan

Contacts

Public ContactRyoma Shimizu

TES Holdings Co., Ltd. Administrative Department of Clinical Trials

r.shimizu@tes-h.co.jp+81-3-6801-8480

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026